ViQi Inc
ViQi empowers scientists to accelerate discoveries, reduce costs, and make advanced therapies more accessible by combining expertise in life sciences, computer science, data science, AI, and business management. They create AI-powered custom assay solutions that seamlessly integrate into workflows, supporting regulatory compliance and operational efficiency. Unlike companies offering off-the-shelf solutions, ViQi excels at developing tailored, AI-driven assays for specific scientific needs, simplifying bioassays to bring innovations to market faster. Their platform offers end-to-end integration, focusing on compliance-driven innovation and reducing the time and costs associated with traditional drug development processes.
ViQi Inc
ViQi empowers scientists to accelerate discoveries, reduce costs, and make advanced therapies more accessible by combining expertise in life sciences, computer science, data science, AI, and business management. They create AI-powered custom assay solutions that seamlessly integrate into workflows, supporting regulatory compliance and operational efficiency. Unlike companies offering off-the-shelf solutions, ViQi excels at developing tailored, AI-driven assays for specific scientific needs, simplifying bioassays to bring innovations to market faster. Their platform offers end-to-end integration, focusing on compliance-driven innovation and reducing the time and costs associated with traditional drug development processes.
TL;DR
Founded: 2017
Headquarters: Santa Barbara, California
Industry: Biotechnology / life-sciences SaaS
Employees: ~12
Total funding: USD 4,005,516 (including grants)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Speeding up and de-risking bioassay development and image-based analysis in drug discovery, diagnostics, and bioprocessing.
Founded
2017
Industry
Biotechnology
Funding Track Record
Most recent listed funding event is a grant announced May 1, 2022.
Early/seed investor listed.
Investor Signal
“Received government grant funding from U.S. Department of Energy and National Science Foundation; has at least one private seed investor.”